Neurotransmitters, hormones, cytokines, growth factors and other ligands transmit their specific messages by binding to receptor molecules on the cell surface. The ligand-bound receptors activate effector systems such as adenylate cyclase, cyclic nueleotide phosphodiesterase, ion channels, and phospholipases via membrane-associated transducing systems to generate second messengers. Receptors activate effector systems via signal transducing elements called GTPbinding proteins (G-proteins) which are heterotrimers composed of a-, B-and y-subunits. When a receptor binds ligands, the G-protein disassociates into the a-and Bysubunits [ 11. The disassociation of subunits is caused by the exchange of GTP for GDP which is bound to the a-subunit. Specific a-subunits are associated with the inhibition of adenylate cyclase and activation of cyclic GMP phosphodiesterase, voltage-sensitive ion channels, adenylate cyclase and phospholipase C. The a-subunits have endogenous GTPase activity which hydrolyses the bound GTP to GDP, resulting in the reassociation of the a -and By-subunits and subsequent termination of the signal [ 11.
GTPase activity which hydrolyses the bound GTP to GDP, resulting in the reassociation of the a -and By-subunits and subsequent termination of the signal [ 11.
Phospholipase A, as an effector enzyme can mediate receptor-induced arachidonic acid release regulated by an unknown G-protein [2] . Phospholipase A, hydrolyses arachidonic acid-containing phospholipids, such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserinc, phosphatidylinositides, phosphatidic acid and plasmalogcns, to generate free arachidonic acid and lysophospholipids. The arachidonic acid is further metabolized by cyclo-oxygenase to prostaglandin and thromboxanes; by lipoxygenase to leukotricnes and hydroxyeicosatetraenoic acids ( HETEs), and by epoxygenases to epoxides. Metabolites of arachidonic acid havc many important biological actions [3, 41. Our intcrest in phospholipase A, as a receptor-mediated effector enzyme stemmed from the initial observation that the chcmotactic peptide, fMetLeuPhe, liberated free arachidonic acid from neutrophils prelabeled with IT-arachidonic acid 151. A direct association between the amount of arachidonic acid released by NetLeuPhe and the extent of chemotaxis was also demonstrated.
Several pathways exist for the receptor-mediated generation o f arachidonic acid. The most direct involves coupling o f the receptor protein with phospholipasc A, activation through a G-protein of unknown character 161. Indirect routes havc been demonstrated involving the releasc of arachidonic acid from diacylglycerol by diglyceridc lipase 171. Diacylglycerol can be generated from the action of phospholipasc C on several phospholipids such as phosphatidylcholine and phosphatidylinositol. Alternatively, arachidonic acid can he released from phosphatidic acid by diglyceride lipase. Phosphatidic acid can be produced from the hydrolysis o f phospholipids by phospholipase D 181. In many studies, receptor-mediated release of arachidonic acid was found to be calcium dependent, while phospholipase C and D are partially or insensitive to calcium [9, lo] .
Noradrenaline via a , -adrenergic recept0r.s liberate urachidonic acid by phosphipuse A , Experiments in our laboratory indicated that a ,-receptormediated release of arachidonic acid occurred by the activation of phospholipase A2, independent of phosphatidylinositol-specific phospholipase C. An opportunity to examine the role of G-proteins and phospholipase A, in the receptor-mediated release of arachidonic acid was made possible by the availability of a rat thyroid cell line, FRTLS, in which thyrotropin (TSH) induced the formation of a , -adrenergic receptors [ 1 11. In these cells, noradrenaline stimulated the release of arachidonic acid and inositol phosphates [ 121, and increased DNA synthesis [ 131. The major metabolic product formed from arachidonic acid was prostaglandin E2 (PGE,). When FRTLS cclls were starved of TSH, noradrenaline increased the incorporation of I 3H lthymidine into DNA. It was later determined that PGE, induced the eicosanoid-stimulated incorporation o f [ jHIthymidine into DNA [ 131. This provided an example where stimulation of an adrenergic receptor o n the cell surface could induce mitogenesis via a cascade of intraccllular signals. Guanosine 5'-[ y-thioltriphosphate (GTPISI) a nonhydrolysable analogue o f GTP which persistently activates G-proteins, stimulated inositol phosphate formation and arachidonic acid release when introduced into permeabilized FRTLS cells [ 121. These findings suggested that arachidonic acid was liberated from a G-protein linked to phospholipasc A,, o r through an alternative pathway involving phospholipase C o r phospholipase D as previously mentioned. The addition of ncomycin, a compound that inhibits phospholipase C, but not phospholipase A,, blocked the stimulation of inositol phosphate formation induced by GTPIS], but not the release o f arachidonic acid. These experiments provided evidence that the GTP[S]-stimulated release of arachidonic acid was due to the activation of phospholipase A,. Further evidence for G-proteincoupled phospholipase A: activation was obtained with the use of pertussis toxin, which prcvents the disassociation o f the a -and by-subunits of the inhibitory G-protein [ 1 1. The toxin inhibited noradrenalinc-and GTPISI-induced release of arachidonic acid in FRTLS cells, but had no effect o n inositol phosphate accumulation. phospholipase A, and release of arachidonic acid was also studied in the brain [14] . In primary cultures of spinal cord neurons, noradrenaline stimulated the release of arachidonic acid as well as the turnover of inositol phosphates via a,-adrenergic receptors. Archidonic acid was found to be released from neurons, while inositol phosphates were released from both neurons and glia cells. Treatment of spinal cord cultures with phorbol esters, which activates protein kinase C, inhibited turnover of inositol phosphates, but increased the noradrenaline-stimulated release of arachidonic acid. Pertussis toxin inhibited inositol phosphate release, but had no effect on the release of arachidonic acid. Extracellular calcium was necessary for the release of arachidonic acid, but not inositol phosphates. Blocking the release of intracellular calcium reduced the production of inositol phosphates, but had little effect on the release of arachidonic acid. These findings indicated that occupation of a,-adrenergic receptors activated the release of arachidonic acid from neurons in primary cultures of spinal cord cells, possibly via phospholipase A, and independent of the activation of phosphatidylinositol-specific phospholipase C. Similarly, a , -adrenergic receptor-mediated release of arachidonic acid via phospholipase A, was also observed in MDCK kidney cells [IS] .
Rrudykitiiti itiduces the releuse ofuruchidonic acid by the uctivution of phospholipase A2
The peptide bradykinin induces the release of arachidonic acid and subsequent prostaglandin synthesis, and also increases inositol phosphate formation [ 161. It is recognized that bradykinin generates inositol phosphates by activating phospholipase C. To examine whether bradykinin stimulated the release of arachidonic acid by the receptor-mediated activation of phospholipase A, and not by the phospholipase C diglyceride lipase pathway, Swiss 3T3 fibroblast cells were used. When these cells were prelabelled with suggested when phorbol esters enhanced the bradykininstimulated formation of PGE2, but inhibited bradykininstimulated inositol phosphate formation. Additional evidence of bradykinin-mediated phospholipase A, activation was suggested with the use of dexamethasone, which has been proposed to inhibit phospholipase A, through the synthesis of lipocortins [ 181. Pretreatment of 3T3 cells with dexamethasone inhibited bradykinin-stimulated PGE, synthesis, but was without effect on inositol phosphate formation [ 171. Taken together, these experiments suggested that bradykinin receptors are coupled to GTP-binding proteins which interact with both phospholipase A, and phospholipase C, and that phospholipase A, is the enzyme that most likely catalyses the release of arachidonic acid for prostaglandin synthesis.
Diacyglycerol (DAG) is a second messenger generated from the action of phospholipase C on phosphatidylinositol-4,5 bisphosphate [ 191. Cell-permeable analogues of DAG, such as 1-oleoyl-2-acetylglycerol (OAG), and phorbol esters were found to potentiate bradykinin-stimulated prostaglandin synthesis in Swiss 3T3 fibroblasts after preincubation of the cells with these agents for a short time (15 min) [2O] . Phorbol esters and DAG analogues by themselves had n o effect on prostaglandin synthesis, nor did they potentiate the effect of bradykinin when incubated with the cells for less than 5 min. Inhibition of protein kinase C with prolonged incubation with phorbol esters (8 h) did not abolish the ability of OAG or phorbol esters to amplify the bradykininstimulated generation of prostaglandins. These agents may increase intracellular calcium levels, which can subsequently activate phospholipase A,, or they might lower the calcium requirements of this enzyme. Evidence for the activation of phospholipase A, by bradykinin in kidney cell cultures, independent of phospholipase C, has been reported [ 15 ].
Light activates phospholipuse A2 in rod outer segmerits of'the retina
The most direct evidence showing that phospholipase A2 can be activated by G-proteins was found by examining the effect of light on the rod outer segments of bovine retina [2 11. Rhodopsin is the light receptor for the rod outer segments and is coupled to cyclic GMP phosphodiesterase via the G-protein, transducin [ 221. Transducin is a heterotrimeric G-protein consisting of a-, B-and y-subunits. When rod outer segments are exposed to light, the a-subunit dissociates from the By-subunit. The a-subunit of transducin then stimulates the enzyme cyclic GMP phosphodiesterase, which then lowers cyclic GMP levels and closes the sodium channel located in the disc membranes of the rod outer segments. Upon closure of the sodium channel, the cell hyperpolarizes and the visual signal is then transmitted to the brain. In darkadapted bovine rod outer segments, light-activated phospholipase A, was measured by the release of II'Clarachidonic acid from the substrate 1-palmitoyl-2-1 I'CIarachidonoylphosphatidylcholine. The addition of GTPIS] to the rod outer segments in the dark also led to the activation of phospholipase A,, presumably due to the disassociation of a-from the &subunit of transducin 1211. Both pertussis toxin and cholera toxin inhibited the activation of phospholipase A, by light [21] , as well as the light-induced increase in cyclic GMP phosphodiesterase activity [22] . With the removal of transducin from the rod outer segments by hypotonic washings in the dark, both the light-and GTP[S]-stimulated phospholipase A, activity was markedly reduced. When purified transducin was added back to the washed rod outer segments, both the light induced-and GTP [S] (in the dark)-stimulated activity of phospholipase A, was mostly restored [21] . These experiments demonstrated that transducin is coupled to phospholipase A, activation in the rod outer segments. The addition of GTP[S] reduced phospholipase A, activity when added in the light. The removal of transducin by washing the rod outer segments, followed by the addition of GTP [S] , inhibited phospholipase A, activity. In these experiments, the removal of transducin by washing the rod outer segments appeared to unmask a G-protein which is inhibitory to phospholipase A,.
The effect of the a-and By-transducin subunits, isolated from bovine rod outer segments, on phospholipase A2 activity was investigated [23] . The a-or By-subunits were added to the transducin-depleted rod outer segments in the dark. The a-subunit caused a slight increase in phospholipase A2 activity. In contrast, the By-subunit markedly stimulated enzyme activity. This was a surprising result, since the a-subunit of transducin has been shown to activate cyclic GMP phosphodiesterase [22] . Addition of equimolar amounts of a-and By-subunits caused an inhibition of phospholipase A? activity in the dark-adapted rod outer segments probably due to the reassociation of the spyheterotrimer of transducin [23] . This was further suggested when the addition of GTP [S] , which causes the disassociation of the a-and By-subunits, blocked the inhibitory effect of the a-subunit. In addition, pertussis toxin treatment of the combined a&-subunits added to the rod outer segments in the light, resulted in a further inhibition of phospholipase A?. It has not yet been established whether the By-subunit can directly stimulate phospholipase A2 or remove an inhibitor of this enzyme. Others have shown that the By-subunit can stimulate calcium-dependent and voltage-sensitive potassium ion channels 124). The By-subunit has also been shown to inhibit adenylate cyclase activity and to interact with calmodulin [ 251, further suggesting a regulatory role for these subunits.
Itirerleitkiri I , phospholipuse A2 arid signal traruditction lnterleukin 1 (IL-1 ) is an important messenger molecule in the immune response and appears to interact with both the nervous and endocrine systems. It is a protein growth factor (molecular mass of 17 SO0 Da) that is produced in many cells including macrophages, fibroblasts, and astrocytes [26] . IL-1 appears to interact with phospholipase A, by increasing prostaglandin (PG) synthesis and inducing the synthesis of phospholipase A, in many cells [27] .
In view of the action of IL-1 on phospholipase A,, we examined the effect of pretreatment of Swiss 3T3 cells with IL-I on the bradykinin receptor-mediated generation of PGEz [28] . Human recombinant IL-la and IL-lB were equipotent in stimulating PGEz synthesis after 1 h of preincubation and the effect of IL-1 was persistent for 2 days. IL-1 augmented bradykinin-stimulated PGEz synthesis. In cells that had been pretreated with IL-1 for 24 h, PG synthesis after bradykinin treatment was increased about 10-fold. IL-1 pretreatment was found to induce synthesis of phospholipase A, and cyclo-oxygenase de tiovo, but not phospholipase C or PGE isomerase. This cytokine did not affect bradykinin receptor number or affinity. IL-1 also increased bradykinin-stimulated GTPase activity, indicating an induction of a putative GTP-binding protein linked to the bradykinin receptor. All of these findings suggested that IL-1 amplified the bradykinin receptor-mediated generation of PGE, by increasing the levels of phospholipase A?, cyclooxygenase and GTP-binding proteins.
Further experiments were undertaken in an AtT-20 mouse pituitary cell line to clarify the role of 1L-1 in receptormediated transmembrane signalling. IL-1 induced the release of B-endorphin in these cells only after 18 h of pretreatment [2Y] . Under the same conditions, IL-1 augmented the corticoid releasing factor (CRF )-and vasoactive intestinal polypeptide(V1P)-stimulated release of /?-endorphin.
Phorbol esters alone stimulated B-endorphin release and augmented secretagogue-stimulated /?-endorphin release after short-term pretreatment. Desensitization of proteinkinase C by prolonged treatment with phorbol esters blocked the effect of IL-1, suggesting a role for protein kinase C in its action. The potentiating effect of IL-1 on CRFinduced /?-endorphin secretion was only partially abolished after desensitization of protein kinase C. In AtT 20 cells, IL-1 could induce a late response, such as the secretion of B-endorphin, by activating receptor-mediated early signals. We have found that IL-1 generates several early signals, the phosphorylation of 20 and 60 kDa proteins and an increase in mRNA for the proto-oncogenes c-fos and c-jun (M. 0. Fargarasan, J. Axelrod & F. Aiello, unpublished work). c-fos and c-jun can form a heterodimer which may act on an enhancer responsive element on genes.
Cloned muscarinic receptors arid sigtiul trarisditctiori by phospholipase A2 arid c'
A family of five muscarinic receptor subtypes have been cloned and are designated m,-m, [30-321. These muscarinic receptors are members of a supergene family which span the membrane seven times and are coupled to G-proteins. Each of the muscarinic receptor genes have been transfected and stably expressed in a mouse AYL fibroblast cell line and activate several second messenger pathways [ 33, 341. Carbachol, a muscarinic receptor agonist inhibited cyclic-AMP generation in transfected AYL cells that expressed the m, and m4 muscarinic receptors. The m,-m3-, and m,-muscarinic receptors, when stimulated with carbachol, generated inositol phosphates, arachidonic acid release and cyclicAMP generation, which were blocked by the muscarinic antagonist atropine. Carbachol-stimulated arachidonic acid release could be due to the stimulation of phospholipase A, or phospholipase C. To distinguish between the activation of these two phospholipases, the transfected cells were treated with phorbol ester and the release of [3H]arachidonic acid and [3H]inositol phosphates were measured. Phorbol ester pretreatment resulted in a marked amplification and acceleration of the carbachol-stimulated release of arachidonic acid [35] . In contrast, phorbol ester pretreatment caused an inhibition of carbachol-stimulated release of inosito1 phosphates in these cells. These results suggest that the major source of the receptor-mediated release of arachidonic acid was due to activation of phospholipase A, and not phospholipase C.
As mentioned above, each of the m,, m,, and m, muscarinic receptors are linked to at least three second messenger systems; adenylate cyclase and cylicAMP accumulation, phospholipase C and inositol phosphate generation, and phospholipase A? and arachidonic acid release. Muscarinic receptors could activate an effector enzyme either directly through a G-protein or indirectly as a consequence of activating another effector enzyme. Studies with phorbol esters previously described indicated that arachidonic acid release and inositol phosphate generation were indepenent second messenger pathways linked to a single receptor [ 351. Arachidonic acid release is unlikely to be secondary to the elevation of the cyclicAMP levels since cyclicAMP analogues and phosphodiesterase inhibitors had no effect on basal and muscarinic receptor-stimulated arachidonic acid release in these transfected cells. Further studies were performed to determine if carbachol-stimulated cyclicAMP elevation was directly or indirectly linked to the m,-muscarinic receptor or was mediated via release of arachidonic acid or inositol phosphate second messengers. Phorbol ester Pretreatment augmented carbachol-stimulated arachidonic release, but inhibited both carbachol-stimulated cyclicAMP accumulation and inositol phosphate release with equal potency [36] .
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Carbachol failed to stimulate cyclicAMP in A9L cell membranes, whereas PGE, did. These and other observations suggested that cyclicAMP accumulation did not occur through direct m,-muscarinic receptor coupling to adenylate cyclase via G,, but was mediated through multiple steps involving activation of phospholipase C, the generation of inositol trisphosphate and cytosolic Ca2 + and stimulation of calmodulin.
Discussion
The mechanisms whereby G-proteins activate phospholipase A2 is not known. Although a number of G-proteins have been characterized, the G-proteins that are coupled to phospholipase A, have not yet been identified. Cholera toxin stimulates G,a, but can also stimulate [37] or inhibit [21] phospholipase A,, depending on the receptor or cell type investigated. Pertussis toxin inhibits G, a [ 11 and transducin [22] , but can inhibit or stimulate phospholipase A, [37] . It appears that there are multiple G-proteins that are linked to phospholipase A, activation. There may be several phospholipase A, iso-enzymes that have different calcium ion requirements, pH optima and intracellular locations, and may have the ability to translocate from cytosol to membrane on activation. Some G-proteins may directly couple a receptor to an effector phospholipase A,. Other G-proteins may modulate phospholipase A, activity by opening calcium channels or by inositol trisphosphate-induced release of calcium from intracellular stores. Phospholipase A? may also be activated or inhibited by protein kinase A or protein kinase C.
Receptor generated archidonic acid and its eicosanoid metabolites can act as second messengers. Arachidonic itself can mobilize cytosolic calcium, independent of inositol trisphosphate formation [38] . The y-subspecies of protein kinase C, from bovine cerebellum, is selectively activated by arachidonic acid [39] . Arachidonic acid and its lipoxygenase metabolites can modulate voltage-gated cardiac potassium channels [24] . In sensory neurons of aplysia, arachidonic acid as its metabolite 12-HPETE can mimic the effect of FMPEamide, which causes an increase in net outward potassium currents 1401. Arachidonic acid and its metabolites can also amplify other second messenger systems such as cyclicAMP [41] , and have been implicated in neurosecretion, as well as transport of ions and amino acids [42] . Lysophosphatidylcholine, the lipid generated by the action phospholipase A2 on phosphatidylcholine, can stimulate cyclicAMP phosphodiesterases and may serve as a messenger for other effector systems.
Arachidonic acid and its metabolites are membrane permeable and can exit from the cell to act as first messengers, thereby activating specific receptors on the cell in which they were formed or on neighbouring cells [2] . They then could activate or inhibit adenylate cyclase, phospholipase C, ion channels or effect other functions on neighbouring cells.
Recent evidence has suggested an important role for arachidonic acid in nervous tissue. 5Hydroxytryptamine-receptor-stimulated phospholipase A, and arachidonic acid release was demonstrated in hippocampal neurons, independent of phospholipase C [43] . N-methyla-aspartate (NMDA), a compound which activates excitatory amino acid receptors on nerve cells, can liberate arachidonic acid from striatal neurons in primary cultures of cerebellar granule cells, possibly by the activation of phospholipase A, [44] . The addition of arachidonic acid to the rat dentate gyrus causes a slow onset and persistent increase in synaptic activity, which is accompanied by an increase in the release of glutamate [45] . It is possible that arachidonic acid and/or its metabolites, produced by the NMDA-receptor-mediated activation of post-synaptic cells, could cross the synaptic cleft to act on presynaptic cells and thus might act as retrograde messenger for long-term potentiation.
